Global Aneurysmal Subarachnoid Hemorrhage Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 178389
  • calendar_today Published On: Mar, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Aneurysmal Subarachnoid Hemorrhage market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Aneurysmal Subarachnoid Hemorrhage size is estimated to be USD 168.9 million in 2025 from USD 156.3 million in 2019, with a change XX% between 2019 and 2020. The global Aneurysmal Subarachnoid Hemorrhage market size is expected to grow at a CAGR of 2.0% for the next five years.

Market segmentation

Aneurysmal Subarachnoid Hemorrhage market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Computed Tomography (CT) Scan

Magnetic Resonance Imaging (MRI)

Lumbar Puncture

Xanthochromia

Cerebral Angiography

Transcranial Doppler Ultrasound

Market segment by Application, can be divided into

Hospitals

Clinics

Others

Market segment by players, this report covers

Edge Therapeutics

Actelion Pharmaceuticals

Arbor Pharmaceuticals

Mayfield Brain & Spine

Europa Group

GE

Philips

Siemens

Trivitron

Toshiba

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Aneurysmal Subarachnoid Hemorrhage

1.2 Classification of Aneurysmal Subarachnoid Hemorrhage by Type

1.2.1 Overview: Global Aneurysmal Subarachnoid Hemorrhage Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Aneurysmal Subarachnoid Hemorrhage Revenue Market Share by Type in 2020

1.2.3 Computed Tomography (CT) Scan

1.2.4 Magnetic Resonance Imaging (MRI)

1.2.5 Lumbar Puncture

1.2.6 Xanthochromia

1.2.7 Cerebral Angiography

1.2.8 Transcranial Doppler Ultrasound

1.3 Global Aneurysmal Subarachnoid Hemorrhage Market by Application

1.3.1 Overview: Global Aneurysmal Subarachnoid Hemorrhage Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Global Aneurysmal Subarachnoid Hemorrhage Market Size & Forecast

1.5 Global Aneurysmal Subarachnoid Hemorrhage Market Size and Forecast by Region

1.5.1 Global Aneurysmal Subarachnoid Hemorrhage Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Aneurysmal Subarachnoid Hemorrhage Market Size by Region, (2016-2021)

1.5.3 North America Aneurysmal Subarachnoid Hemorrhage Market Size and Prospect (2016-2026)

1.5.4 Europe Aneurysmal Subarachnoid Hemorrhage Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Market Size and Prospect (2016-2026)

1.5.6 South America Aneurysmal Subarachnoid Hemorrhage Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Aneurysmal Subarachnoid Hemorrhage Market Drivers

1.6.2 Aneurysmal Subarachnoid Hemorrhage Market Restraints

1.6.3 Aneurysmal Subarachnoid Hemorrhage Trends Analysis

2 Company Profiles

2.1 Edge Therapeutics

2.1.1 Edge Therapeutics Details

2.1.2 Edge Therapeutics Major Business

2.1.3 Edge Therapeutics Aneurysmal Subarachnoid Hemorrhage Product and Solutions

2.1.4 Edge Therapeutics Aneurysmal Subarachnoid Hemorrhage Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Edge Therapeutics Recent Developments and Future Plans

2.2 Actelion Pharmaceuticals

2.2.1 Actelion Pharmaceuticals Details

2.2.2 Actelion Pharmaceuticals Major Business

2.2.3 Actelion Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Product and Solutions

2.2.4 Actelion Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Actelion Pharmaceuticals Recent Developments and Future Plans

2.3 Arbor Pharmaceuticals

2.3.1 Arbor Pharmaceuticals Details

2.3.2 Arbor Pharmaceuticals Major Business

2.3.3 Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Product and Solutions

2.3.4 Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Arbor Pharmaceuticals Recent Developments and Future Plans

2.4 Mayfield Brain & Spine

2.4.1 Mayfield Brain & Spine Details

2.4.2 Mayfield Brain & Spine Major Business

2.4.3 Mayfield Brain & Spine Aneurysmal Subarachnoid Hemorrhage Product and Solutions

2.4.4 Mayfield Brain & Spine Aneurysmal Subarachnoid Hemorrhage Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Mayfield Brain & Spine Recent Developments and Future Plans

2.5 Europa Group

2.5.1 Europa Group Details

2.5.2 Europa Group Major Business

2.5.3 Europa Group Aneurysmal Subarachnoid Hemorrhage Product and Solutions

2.5.4 Europa Group Aneurysmal Subarachnoid Hemorrhage Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Europa Group Recent Developments and Future Plans

2.6 GE

2.6.1 GE Details

2.6.2 GE Major Business

2.6.3 GE Aneurysmal Subarachnoid Hemorrhage Product and Solutions

2.6.4 GE Aneurysmal Subarachnoid Hemorrhage Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 GE Recent Developments and Future Plans

2.7 Philips

2.7.1 Philips Details

2.7.2 Philips Major Business

2.7.3 Philips Aneurysmal Subarachnoid Hemorrhage Product and Solutions

2.7.4 Philips Aneurysmal Subarachnoid Hemorrhage Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Philips Recent Developments and Future Plans

2.8 Siemens

2.8.1 Siemens Details

2.8.2 Siemens Major Business

2.8.3 Siemens Aneurysmal Subarachnoid Hemorrhage Product and Solutions

2.8.4 Siemens Aneurysmal Subarachnoid Hemorrhage Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Siemens Recent Developments and Future Plans

2.9 Trivitron

2.9.1 Trivitron Details

2.9.2 Trivitron Major Business

2.9.3 Trivitron Aneurysmal Subarachnoid Hemorrhage Product and Solutions

2.9.4 Trivitron Aneurysmal Subarachnoid Hemorrhage Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Trivitron Recent Developments and Future Plans

2.10 Toshiba

2.10.1 Toshiba Details

2.10.2 Toshiba Major Business

2.10.3 Toshiba Aneurysmal Subarachnoid Hemorrhage Product and Solutions

2.10.4 Toshiba Aneurysmal Subarachnoid Hemorrhage Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Toshiba Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Aneurysmal Subarachnoid Hemorrhage Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 5 Aneurysmal Subarachnoid Hemorrhage Players Market Share

3.2.2 Top 10 Aneurysmal Subarachnoid Hemorrhage Players Market Share

3.2.3 Market Competition Trend

3.3 Aneurysmal Subarachnoid Hemorrhage Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Aneurysmal Subarachnoid Hemorrhage Revenue and Market Share by Type (2016-2021)

4.2 Global Aneurysmal Subarachnoid Hemorrhage Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Aneurysmal Subarachnoid Hemorrhage Revenue Market Share by Application (2016-2021)

5.2 Aneurysmal Subarachnoid Hemorrhage Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Aneurysmal Subarachnoid Hemorrhage Revenue by Type (2016-2026)

6.2 North America Aneurysmal Subarachnoid Hemorrhage Revenue by Application (2016-2026)

6.3 North America Aneurysmal Subarachnoid Hemorrhage Market Size by Country

6.3.1 North America Aneurysmal Subarachnoid Hemorrhage Revenue by Country (2016-2026)

6.3.2 United States Aneurysmal Subarachnoid Hemorrhage Market Size and Forecast (2016-2026)

6.3.3 Canada Aneurysmal Subarachnoid Hemorrhage Market Size and Forecast (2016-2026)

6.3.4 Mexico Aneurysmal Subarachnoid Hemorrhage Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Aneurysmal Subarachnoid Hemorrhage Revenue by Type (2016-2026)

7.2 Europe Aneurysmal Subarachnoid Hemorrhage Revenue by Application (2016-2026)

7.3 Europe Aneurysmal Subarachnoid Hemorrhage Market Size by Country

7.3.1 Europe Aneurysmal Subarachnoid Hemorrhage Revenue by Country (2016-2026)

7.3.2 Germany Aneurysmal Subarachnoid Hemorrhage Market Size and Forecast (2016-2026)

7.3.3 France Aneurysmal Subarachnoid Hemorrhage Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Aneurysmal Subarachnoid Hemorrhage Market Size and Forecast (2016-2026)

7.3.5 Russia Aneurysmal Subarachnoid Hemorrhage Market Size and Forecast (2016-2026)

7.3.6 Italy Aneurysmal Subarachnoid Hemorrhage Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Revenue by Type (2016-2026)

8.2 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Revenue by Application (2016-2026)

8.3 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Market Size by Region

8.3.1 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Revenue by Region (2016-2026)

8.3.2 China Aneurysmal Subarachnoid Hemorrhage Market Size and Forecast (2016-2026)

8.3.3 Japan Aneurysmal Subarachnoid Hemorrhage Market Size and Forecast (2016-2026)

8.3.4 South Korea Aneurysmal Subarachnoid Hemorrhage Market Size and Forecast (2016-2026)

8.3.5 India Aneurysmal Subarachnoid Hemorrhage Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Aneurysmal Subarachnoid Hemorrhage Market Size and Forecast (2016-2026)

8.3.7 Australia Aneurysmal Subarachnoid Hemorrhage Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Aneurysmal Subarachnoid Hemorrhage Revenue by Type (2016-2026)

9.2 South America Aneurysmal Subarachnoid Hemorrhage Revenue by Application (2016-2026)

9.3 South America Aneurysmal Subarachnoid Hemorrhage Market Size by Country

9.3.1 South America Aneurysmal Subarachnoid Hemorrhage Revenue by Country (2016-2026)

9.3.2 Brazil Aneurysmal Subarachnoid Hemorrhage Market Size and Forecast (2016-2026)

9.3.3 Argentina Aneurysmal Subarachnoid Hemorrhage Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Revenue by Type (2016-2026)

10.2 Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Revenue by Application (2016-2026)

10.3 Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Market Size by Country

10.3.1 Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Revenue by Country (2016-2026)

10.3.2 Turkey Aneurysmal Subarachnoid Hemorrhage Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Aneurysmal Subarachnoid Hemorrhage Market Size and Forecast (2016-2026)

10.3.4 UAE Aneurysmal Subarachnoid Hemorrhage Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Aneurysmal Subarachnoid Hemorrhage Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Aneurysmal Subarachnoid Hemorrhage Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Aneurysmal Subarachnoid Hemorrhage Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Aneurysmal Subarachnoid Hemorrhage Revenue (USD Million) by Region (2016-2021)

Table 5. Global Aneurysmal Subarachnoid Hemorrhage Revenue Market Share by Region (2021-2026)

Table 6. Edge Therapeutics Corporate Information, Head Office, and Major Competitors

Table 7. Edge Therapeutics Major Business

Table 8. Edge Therapeutics Aneurysmal Subarachnoid Hemorrhage Product and Solutions

Table 9. Edge Therapeutics Aneurysmal Subarachnoid Hemorrhage Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Actelion Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 11. Actelion Pharmaceuticals Major Business

Table 12. Actelion Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Product and Solutions

Table 13. Actelion Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Arbor Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 15. Arbor Pharmaceuticals Major Business

Table 16. Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Product and Solutions

Table 17. Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Mayfield Brain & Spine Corporate Information, Head Office, and Major Competitors

Table 19. Mayfield Brain & Spine Major Business

Table 20. Mayfield Brain & Spine Aneurysmal Subarachnoid Hemorrhage Product and Solutions

Table 21. Mayfield Brain & Spine Aneurysmal Subarachnoid Hemorrhage Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Europa Group Corporate Information, Head Office, and Major Competitors

Table 23. Europa Group Major Business

Table 24. Europa Group Aneurysmal Subarachnoid Hemorrhage Product and Solutions

Table 25. Europa Group Aneurysmal Subarachnoid Hemorrhage Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. GE Corporate Information, Head Office, and Major Competitors

Table 27. GE Major Business

Table 28. GE Aneurysmal Subarachnoid Hemorrhage Product and Solutions

Table 29. GE Aneurysmal Subarachnoid Hemorrhage Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Philips Corporate Information, Head Office, and Major Competitors

Table 31. Philips Major Business

Table 32. Philips Aneurysmal Subarachnoid Hemorrhage Product and Solutions

Table 33. Philips Aneurysmal Subarachnoid Hemorrhage Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Siemens Corporate Information, Head Office, and Major Competitors

Table 35. Siemens Major Business

Table 36. Siemens Aneurysmal Subarachnoid Hemorrhage Product and Solutions

Table 37. Siemens Aneurysmal Subarachnoid Hemorrhage Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Trivitron Corporate Information, Head Office, and Major Competitors

Table 39. Trivitron Major Business

Table 40. Trivitron Aneurysmal Subarachnoid Hemorrhage Product and Solutions

Table 41. Trivitron Aneurysmal Subarachnoid Hemorrhage Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Toshiba Corporate Information, Head Office, and Major Competitors

Table 43. Toshiba Major Business

Table 44. Toshiba Aneurysmal Subarachnoid Hemorrhage Product and Solutions

Table 45. Toshiba Aneurysmal Subarachnoid Hemorrhage Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Global Aneurysmal Subarachnoid Hemorrhage Revenue (USD Million) by Players (2019-2021)

Table 47. Global Aneurysmal Subarachnoid Hemorrhage Revenue Share by Players (2019-2021)

Table 48. Breakdown of Aneurysmal Subarachnoid Hemorrhage by Company Type (Tier 1, Tier 2 and Tier 3)

Table 49. Aneurysmal Subarachnoid Hemorrhage Players Head Office, Products and Services Provided

Table 50. Aneurysmal Subarachnoid Hemorrhage Mergers & Acquisitions in the Past Five Years

Table 51. Aneurysmal Subarachnoid Hemorrhage New Entrants and Expansion Plans

Table 52. Global Aneurysmal Subarachnoid Hemorrhage Revenue (USD Million) by Type (2016-2021)

Table 53. Global Aneurysmal Subarachnoid Hemorrhage Revenue Share by Type (2016-2021)

Table 54. Global Aneurysmal Subarachnoid Hemorrhage Revenue Forecast by Type (2021-2026)

Table 55. Global Aneurysmal Subarachnoid Hemorrhage Revenue by Application (2016-2021)

Table 56. Global Aneurysmal Subarachnoid Hemorrhage Revenue Forecast by Application (2021-2026)

Table 57. North America Aneurysmal Subarachnoid Hemorrhage Revenue by Type (2016-2021) & (USD Million)

Table 58. North America Aneurysmal Subarachnoid Hemorrhage Revenue by Type (2021-2026) & (USD Million)

Table 59. North America Aneurysmal Subarachnoid Hemorrhage Revenue by Application (2016-2021) & (USD Million)

Table 60. North America Aneurysmal Subarachnoid Hemorrhage Revenue by Application (2021-2026) & (USD Million)

Table 61. North America Aneurysmal Subarachnoid Hemorrhage Revenue by Country (2016-2021) & (USD Million)

Table 62. North America Aneurysmal Subarachnoid Hemorrhage Revenue by Country (2021-2026) & (USD Million)

Table 63. Europe Aneurysmal Subarachnoid Hemorrhage Revenue by Type (2016-2021) & (USD Million)

Table 64. Europe Aneurysmal Subarachnoid Hemorrhage Revenue by Type (2021-2026) & (USD Million)

Table 65. Europe Aneurysmal Subarachnoid Hemorrhage Revenue by Application (2016-2021) & (USD Million)

Table 66. Europe Aneurysmal Subarachnoid Hemorrhage Revenue by Application (2021-2026) & (USD Million)

Table 67. Europe Aneurysmal Subarachnoid Hemorrhage Revenue by Country (2016-2021) & (USD Million)

Table 68. Europe Aneurysmal Subarachnoid Hemorrhage Revenue by Country (2021-2026) & (USD Million)

Table 69. Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Revenue by Type (2016-2021) & (USD Million)

Table 70. Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Revenue by Type (2021-2026) & (USD Million)

Table 71. Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Revenue by Application (2016-2021) & (USD Million)

Table 72. Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Revenue by Application (2021-2026) & (USD Million)

Table 73. Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Revenue by Region (2016-2021) & (USD Million)

Table 74. Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Revenue by Region (2021-2026) & (USD Million)

Table 75. South America Aneurysmal Subarachnoid Hemorrhage Revenue by Type (2016-2021) & (USD Million)

Table 76. South America Aneurysmal Subarachnoid Hemorrhage Revenue by Type (2021-2026) & (USD Million)

Table 77. South America Aneurysmal Subarachnoid Hemorrhage Revenue by Application (2016-2021) & (USD Million)

Table 78. South America Aneurysmal Subarachnoid Hemorrhage Revenue by Application (2021-2026) & (USD Million)

Table 79. South America Aneurysmal Subarachnoid Hemorrhage Revenue by Country (2016-2021) & (USD Million)

Table 80. South America Aneurysmal Subarachnoid Hemorrhage Revenue by Country (2021-2026) & (USD Million)

Table 81. Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Revenue by Type (2016-2021) & (USD Million)

Table 82. Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Revenue by Type (2021-2026) & (USD Million)

Table 83. Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Revenue by Application (2016-2021) & (USD Million)

Table 84. Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Revenue by Application (2021-2026) & (USD Million)

Table 85. Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Revenue by Country (2016-2021) & (USD Million)

Table 86. Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Aneurysmal Subarachnoid Hemorrhage Picture

Figure 2. Global Aneurysmal Subarachnoid Hemorrhage Revenue Market Share by Type in 2020

Figure 3. Computed Tomography (CT) Scan

Figure 4. Magnetic Resonance Imaging (MRI)

Figure 5. Lumbar Puncture

Figure 6. Xanthochromia

Figure 7. Cerebral Angiography

Figure 8. Transcranial Doppler Ultrasound

Figure 9. Aneurysmal Subarachnoid Hemorrhage Revenue Market Share by Application in 2020

Figure 10. Hospitals Picture

Figure 11. Clinics Picture

Figure 12. Others Picture

Figure 13. Global Aneurysmal Subarachnoid Hemorrhage Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 14. Global Aneurysmal Subarachnoid Hemorrhage Revenue and Forecast (2016-2026) & (USD Million)

Figure 15. Global Aneurysmal Subarachnoid Hemorrhage Revenue Market Share by Region (2016-2026)

Figure 16. Global Aneurysmal Subarachnoid Hemorrhage Revenue Market Share by Region in 2020

Figure 17. North America Aneurysmal Subarachnoid Hemorrhage Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Europe Aneurysmal Subarachnoid Hemorrhage Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. South America Aneurysmal Subarachnoid Hemorrhage Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. Aneurysmal Subarachnoid Hemorrhage Market Drivers

Figure 22. Aneurysmal Subarachnoid Hemorrhage Market Restraints

Figure 23. Aneurysmal Subarachnoid Hemorrhage Market Trends

Figure 24. Edge Therapeutics Recent Developments and Future Plans

Figure 25. Actelion Pharmaceuticals Recent Developments and Future Plans

Figure 26. Arbor Pharmaceuticals Recent Developments and Future Plans

Figure 27. Mayfield Brain & Spine Recent Developments and Future Plans

Figure 28. Europa Group Recent Developments and Future Plans

Figure 29. GE Recent Developments and Future Plans

Figure 30. Philips Recent Developments and Future Plans

Figure 31. Siemens Recent Developments and Future Plans

Figure 32. Trivitron Recent Developments and Future Plans

Figure 33. Toshiba Recent Developments and Future Plans

Figure 35. Global Aneurysmal Subarachnoid Hemorrhage Revenue Share by Players in 2020

Figure 36. Aneurysmal Subarachnoid Hemorrhage Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 37. Global Top 3 Players Aneurysmal Subarachnoid Hemorrhage Revenue Market Share in 2020

Figure 38. Global Top 10 Players Aneurysmal Subarachnoid Hemorrhage Revenue Market Share in 2020

Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 40. Global Aneurysmal Subarachnoid Hemorrhage Revenue Share by Type in 2020

Figure 41. Global Aneurysmal Subarachnoid Hemorrhage Market Share Forecast by Type (2021-2026)

Figure 42. Global Aneurysmal Subarachnoid Hemorrhage Revenue Share by Application in 2020

Figure 43. Global Aneurysmal Subarachnoid Hemorrhage Market Share Forecast by Application (2021-2026)

Figure 44. North America Aneurysmal Subarachnoid Hemorrhage Sales Market Share by Type (2016-2026)

Figure 45. North America Aneurysmal Subarachnoid Hemorrhage Sales Market Share by Application (2016-2026)

Figure 46. North America Aneurysmal Subarachnoid Hemorrhage Revenue Market Share by Country (2016-2026)

Figure 47. United States Aneurysmal Subarachnoid Hemorrhage Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 48. Canada Aneurysmal Subarachnoid Hemorrhage Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. Mexico Aneurysmal Subarachnoid Hemorrhage Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Europe Aneurysmal Subarachnoid Hemorrhage Sales Market Share by Type (2016-2026)

Figure 51. Europe Aneurysmal Subarachnoid Hemorrhage Sales Market Share by Application (2016-2026)

Figure 52. Europe Aneurysmal Subarachnoid Hemorrhage Revenue Market Share by Country (2016-2026)

Figure 53. Germany Aneurysmal Subarachnoid Hemorrhage Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. France Aneurysmal Subarachnoid Hemorrhage Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. United Kingdom Aneurysmal Subarachnoid Hemorrhage Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Russia Aneurysmal Subarachnoid Hemorrhage Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Italy Aneurysmal Subarachnoid Hemorrhage Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Sales Market Share by Type (2016-2026)

Figure 59. Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Sales Market Share by Application (2016-2026)

Figure 60. Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Revenue Market Share by Region (2016-2026)

Figure 61. China Aneurysmal Subarachnoid Hemorrhage Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Japan Aneurysmal Subarachnoid Hemorrhage Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. South Korea Aneurysmal Subarachnoid Hemorrhage Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. India Aneurysmal Subarachnoid Hemorrhage Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. Southeast Asia Aneurysmal Subarachnoid Hemorrhage Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Australia Aneurysmal Subarachnoid Hemorrhage Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. South America Aneurysmal Subarachnoid Hemorrhage Sales Market Share by Type (2016-2026)

Figure 68. South America Aneurysmal Subarachnoid Hemorrhage Sales Market Share by Application (2016-2026)

Figure 69. South America Aneurysmal Subarachnoid Hemorrhage Revenue Market Share by Country (2016-2026)

Figure 70. Brazil Aneurysmal Subarachnoid Hemorrhage Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. Argentina Aneurysmal Subarachnoid Hemorrhage Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Sales Market Share by Type (2016-2026)

Figure 73. Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Sales Market Share by Application (2016-2026)

Figure 74. Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Revenue Market Share by Country (2016-2026)

Figure 75. Turkey Aneurysmal Subarachnoid Hemorrhage Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Saudi Arabia Aneurysmal Subarachnoid Hemorrhage Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. UAE Aneurysmal Subarachnoid Hemorrhage Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. Methodology

Figure 79. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz